Company intelligence / Profile preview

O2 Insights

Ohio, United States

Ownership: Private
Development stage: Other

Overview

O2 Insights developed rapid, easy-to-use, and affordable point-of-care diagnostic devices for tissue oxygenation, aiming to address key limitations of legacy transcutaneous oxygen monitoring; its technology was acquired by Systagenix in 2012 for integration into their wound diagnostics portfolio.

Therapeutic areas: CardiovascularDermatology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Systagenix (acquirer, wound diagnostics leader)

Beyond the preview

Go deeper on O2 Insights.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on O2 Insights.

Explore the full profile